TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer.

Br J Cancer · 2008 · PMC2600693 · PMID 19002168

Europe PMC DOI

hedged sentence

0.0009

closest p · 0.0× alpha

0.0009

boldest claim

The sentences

highly significantP =0.0009actually significant

Staining intensity for TEAD1 showed a clear overlap in patient survival for groups 1 and 2, and patients with the highest intensity staining (group 3) had a highly significant reduced survival rate ( P =0.0009) ( Figure 3B ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.